SCHEMBL24240366

SCHEMBL24240366

COc1cc(N(C)CCN(C)C)c([N+](=O)[O-])cc1Nc1ncnc(Nc2ccccc2C(=N)F)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 17/20 0.47
PTK2 Q05397 3/20 0.47
ALK Q9UM73 6/20 0.42
EML4 Q9HC35 5/20 0.42
KCNH2 Q12809 2/20 0.42
MLNR O43193 1/20 0.41
KDM1A O60341 1/20 0.41
ABCB11 O95342 1/20 0.41
ERBB2 P04626 1/20 0.41
INSR P06213 1/20 0.41
CHRM2 P08172 1/20 0.41
HTR1A P08908 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
DRD2 P14416 1/20 0.41
NQO2 P16083 1/20 0.41
ADRA2C P18825 1/20 0.41
DRD1 P21728 1/20 0.41
ERBB3 P21860 1/20 0.41
SLC6A2 P23975 1/20 0.41
HTR2A P28223 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22509245 0.90 EGFR (0.48) EGFRPTK2KCNH2
SCHEMBL22509168 0.85 PTK2 (0.51) EGFRPTK2ALKEML4KCNH2
SCHEMBL19336965 0.84 EGFR (0.48) EGFRALKEML4KCNH2MLNR
SCHEMBL22509271 0.83 PTK2 (0.48) PTK2ALKINSRKDRJAK3
SCHEMBL22415729 0.82 EGFR (0.65) EGFRALKEML4KCNH2MLNR
SCHEMBL19337022 0.81 EGFR (0.47) EGFRALKEML4KCNH2MLNR
SCHEMBL30041502 0.80 EGFR (0.51) EGFRALKEML4KCNH2
SCHEMBL24663099 0.79 EGFR (0.41) EGFRALKEML4KCNH2ERBB3
SCHEMBL26324498 0.79 EGFR (0.51) EGFRALKEML4
SCHEMBL19337153 0.78 EGFR (0.50) EGFRALKEML4KCNH2MLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3950686-A1 N-HETEROAROMATIC AMIDE DERIVATIVES FOR TREATMENT OF CANCER Shenzhen Forward Pharmaceuticals Co., Ltd. (CN) 2022-02-09 EP disclosed